Weight-Loss Jab's Hidden Cost: Shocking Hair Loss

Weight-loss medications, including Mounjaro and Ozempic, have gained popularity for their efficacy in shedding pounds and improving health. However, a distressing side effect, significant hair loss, is increasingly reported by users. While some experts suggest nutritional deficiencies from dieting cause this shedding, many individuals experience it despite maintaining a healthy diet and losing weight gradually.

A recent US study indicated a higher incidence of 'telogen effluvium' and 'androgenic alopecia' in women taking semaglutide. This has fueled concerns that these GLP-1 drugs might trigger early-onset female pattern baldness, potentially due to hormonal imbalances. Medical professionals are exploring the link between these medications and hair loss, with some suggesting pharmaceutical companies should fund further research into the phenomenon.

While some cases are temporary, stemming from stress or nutritional factors, the possibility of permanent hair loss remains a significant worry for many. Experts emphasize seeking professional advice and proper screening for deficiencies, cautioning against unverified social media claims and 'miracle cures' that exploit these fears.